General, 22 October 2020 EOSC: shaping Europe’s digital future EMBL’s Rupert Lück is helping to develop the European Open Science Cloud (EOSC): the infrastructure that will support the future of data sharing and analysis in Europe. It is a joint initiative between the European Commission, the EU member states and associated countries, and other stakeholders, which aims to solve data challenges by building a trusted and open virtual environment for the scientific community and others.
Heidelberg, 19 October 2020 EMBL forms new collaborations in France EMBL and CIML have signed a memorandum of understanding that will open up new scientific opportunities. CIML is a joint research unit of Aix-Marseille Université, the Centre national de la recherche scientifique (CNRS), and the Institut national de la santé et de la recherche médicale (Inserm).
Hamburg, 16 October 2020 Welcome: Meytal Landau Amyloids are protein aggregates known for their role in neurodegenerative diseases like Alzheimer’s or Parkinson’s. They’re also secreted by some bacteria. During a one-year sabbatical at EMBL Hamburg, Israeli structural biologist Meytal Landau made use of the site's infrastructure to deepen her study of amyloids in bacteria and in human diseases. She has now joined EMBL as an associate group leader.
Hinxton, 15 October 2020 Repurposing drugs for a pan-coronavirus treatment Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three pathogenic coronaviruses. They also found potential drugs that could be repurposed as COVID-19 treatments, and against emerging coronavirus strains in the future.
General, 15 October 2020 Respecting diversity: the role of the scientist Maria Arruda is on a mission to make scientists think more about the role they play in society. After a career in academia and the life sciences, she is trying to help others see the bigger picture when it comes to the responsibility of the scientist. She has been invited to speak at EMBL on 21 October.
Heidelberg, 14 October 2020 Seeing evolution happening before your eyes Researchers from EMBL Heidelberg established an automated pipeline to create mutations in genomic enhancers that let them watch evolution unfold before their eyes. Their findings on fruit flies may also be relevant to the understanding of human diseases, requiring researchers to reassess assumptions about how enhancers contribute to human health.
Hamburg, 13 October 2020 How deadly parasites ‘glide’ into human cells A group of scientists led by EMBL Hamburg’s Christian Löw provide insights into the molecular structure of proteins involved in the gliding movements through which the parasites causing malaria and toxoplasmosis invade human cells.